Skip to main content

Table 2 Threshold effect of PLC on the mortality risk of COVID-19 in piecewise linear regression

From: Association between peripheral lymphocyte count and the mortality risk of COVID-19 inpatients

Inflection point of PLC

The mortality risk of COVID-19a

OR (95% CI)

P value

 < 0.95 × 109/L

0.00 (0.00, 0.05)

0.0041

 > 0.95 × 109/L

4.59 (0.35, 59.80)

0.2442

Log-likelihood ratio test

 

0.001

  1. PLC peripheral lymphocyte count, COVID-19 coronavirus disease 2019, CK creatine kinase, CK-MB creatine kinase isoenzymes, PT prothrombin time
  2. aAdjust for: gender, age, smoking, diabetes mellitus, heart rate at admission, serum albumin, CK, CK-MB, uric acid, PT, and D-dimer
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us